Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease
Phase 3
- Conditions
- Crohn's Disease
- First Posted Date
- 2012-03-08
- Last Posted Date
- 2012-03-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT01548014
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing One-lung Ventilation for Lung Surgery
Not Applicable
Completed
- Conditions
- Lung CancerOne Lung VentilationGas ExchangeInverse-ratio Ventilation
- First Posted Date
- 2012-02-28
- Last Posted Date
- 2013-12-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 110
- Registration Number
- NCT01540201
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
pazopanib_NCRCC,Ph2 STUDY
Phase 2
Completed
- Conditions
- Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma
- Interventions
- First Posted Date
- 2012-02-24
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT01538238
- Locations
- 🇰🇷
Samsung medical Center, Seoul, Korea, Republic of
Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease
Phase 2
Withdrawn
- Conditions
- Pulmonary Non-tuberculous Mycobacterial Lung Disease
- Interventions
- First Posted Date
- 2012-02-08
- Last Posted Date
- 2012-12-17
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT01528930
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Interventions to Enhance Medication Persistence and Compliance in Patients With Overactive Bladder
Not Applicable
Completed
- Conditions
- Overactive Bladder
- Interventions
- Behavioral: Health education intervention (HEI)
- First Posted Date
- 2012-01-24
- Last Posted Date
- 2020-03-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 692
- Registration Number
- NCT01515722
- Locations
- 🇰🇷
Bucheon St. Mary's Hospital, The Catholic University of Korea, Bucheon, Korea, Republic of
🇰🇷Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea, Republic of
🇰🇷Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea, Republic of
LOXL1 Polymorphism in Pseudoexfoliation Syndrome
- Conditions
- Pseudoexfoliation Syndrome
- First Posted Date
- 2012-01-24
- Last Posted Date
- 2012-01-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT01515735
- Locations
- 🇰🇷
Samsung medical center, Seoul, Korea, Republic of
Safety and Efficacy of Photodynamic Therapy for Bile Duct Invasion of Hepatocellular Carcinoma
Not Applicable
Completed
- Conditions
- Hepatocellular CarcinomaObstructive Jaundice
- Interventions
- First Posted Date
- 2012-01-09
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 11
- Registration Number
- NCT01506115
- Locations
- 🇰🇷
Samsung Medical Center 81 Irwon-Ro Gangnamgu, Seoul, Korea, Republic of
Duration of Antibiotics Treatment With Cefazolin and Clarithromycin in Women With Preterm Premature Rupture of Membrane
Phase 3
Completed
- Conditions
- Preterm Premature Rupture of Membrane
- Interventions
- First Posted Date
- 2012-01-04
- Last Posted Date
- 2022-04-20
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 151
- Registration Number
- NCT01503606
- Locations
- 🇰🇷
Samsung Medical center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients
Not Applicable
Completed
- Conditions
- Overactive Bladder
- Interventions
- Drug: Oxybutinin, Fesoterodine, Solifenacin, Propiverin, Trospium
- First Posted Date
- 2011-12-26
- Last Posted Date
- 2019-12-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 191
- Registration Number
- NCT01499069
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Genome-wide Association Study
Withdrawn
- Conditions
- Esophageal Squamous Cell Carcinoma
- First Posted Date
- 2011-12-23
- Last Posted Date
- 2019-05-21
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT01498757
- Locations
- 🇰🇷
Samsung medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath